Avanos Medical (AVNS) Operating Leases (2019 - 2026)

Avanos Medical (AVNS) has 8 years of Operating Leases data on file, last reported at $29.8 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Leases rose 29.0% year-over-year to $29.8 million; the trailing twelve-month figure through Mar 2026 stood at $29.8 million (up 29.0% YoY), and the FY2025 full-year result was $20.4 million, down 42.54% from the prior year.
• Operating Leases grew to $29.8 million in Q1 2026, from $20.4 million in the prior quarter.
• In the past five years, Operating Leases ranged from a high of $41.1 million in Q4 2023 to a low of $20.4 million in Q4 2025.
• A 5-year average of $30.3 million and a median of $29.8 million in 2026 frame the typical range for Operating Leases.
• Across the five-year window, Operating Leases slumped 42.54% in 2025 and rose 29.0% in 2026, its largest moves.
• Tracing AVNS's Operating Leases over 5 years: stood at $32.5 million in 2022, then rose by 26.46% to $41.1 million in 2023, then declined by 13.63% to $35.5 million in 2024, then tumbled by 42.54% to $20.4 million in 2025, then soared by 46.08% to $29.8 million in 2026.
• Business Quant data shows AVNS's Operating Leases at $29.8 million in Q1 2026, $20.4 million in Q4 2025, and $21.4 million in Q3 2025.